The Inflation Reduction Act Aims To Lower Drug Costs — But Here’s How Big Pharma Could Get Around It

The Inflation Reduction Act is set to lower drug prices for millions of people in the U.S. — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many. The law takes aim at insulin costs, caps out-of-pocket spending for Medicare beneficiaries, and allows the federal government to ...

Read More

California Poised To Extend COVID-19 Supplemental Paid Sick Leave Requirements

With current COVID-19 Supplemental Paid Sick Leave (SPSL) requirements set to expire on September 30, the California Legislature has passed California Assembly Bill 152 (AB 152), which now awaits Governor Gavin Newsom’s signature.

Read More

U.S. Employers Brace For Healthcare Costs To Rise Next 3 Years

Businesses continue to struggle with ever-rising healthcare costs with 7 in 10 employers expecting moderate to significant increases in what they pay for healthcare benefits over the next three years.

Read More

Supply For Moderna’s Omicron Booster Hits Snag

Two weeks after the CDC and FDA authorized Moderna's bivalent omicron booster for emergency use, doses are running out in a few U.S. states.

Read More

Biden Says the Pandemic Is Over. But at Least 400 People Are Dying Daily.

With 400 to 500 Americans still dying every day of Covid-19, President Biden has declared that “the pandemic is over.”

Read More

The Cost Of Long COVID To Employers Is Skyrocketing

Have you been wondering whether long COVID was a true post-virus symptom? Now it has been officially confirmed – because researchers have put a price tag on what its costing employer sponsored health plans.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square